Research Group: Cancer
The Cancer Research Group conducts research projects on
- Incidence and risk factors for developing cancer in HIV-positive children and adults in low-, middle- and high-income countries.
- Provision of health care and survival in HIV-positive patients with cancer in low-, middle- and high-income countries.
- Etiological studies
- Cervical cancer screening studies in HIV-positive women
- Evidence-synthesis of oncological interventions
Group members
Group leader
- Name / Titel
- Rohner Eliane, MD MSc
- Funktion
- Head of Research Group
- eliane.rohner@ispm.unibe.ch
- Phone
- +41 31 684 34 72
Group members
- Name / Titel
- Egger Matthias, Prof. Dr. med., MSc FFPH DTM&H
- Funktion
- Head of Research Group
- matthias.egger@ispm.unibe.ch
- Phone
- +41 31 684 35 01
- Name / Titel
- Schmidlin Kurt, Dr. med. dent., MPH
- Funktion
- Senior Research Fellow
- kurt.schmidlin@ispm.unibe.ch
- Phone
- +41 31 684 36 73
- Name / Titel
- Spoerri Adrian, PhD, MPH
- Funktion
- Head of Research Group
- adrian.spoerri@ispm.unibe.ch
- Phone
- +41 31 684 35 50
- Name / Titel
- Taghavi Katayoun, Dr. med., FRANZCOG, MMedSc
- Funktion
- PhD student
- katayoun.taghavi@ispm.unibe.ch
- Phone
- +41 31 684 34 72
- Name / Titel
- Zwahlen Marcel, Prof., PhD
- Funktion
- Deputy Director
- marcel.zwahlen@ispm.unibe.ch
- Phone
- +41 31 684 35 54
Ongoing projects
Ongoing projects
- Creating a South African HIV cohort with cancer outcomes based on routine laboratory data: The South African Cancer Match Study (SAM)
Adrian Spörri, Eliane Rohner, Matthias Egger, Julia Bohlius - Comparison of cervical cancer screening strategies for HIV-positive women in Zambia
Katayoun Taghavi, Nicola Low, Julia Bohlius - The Cervical Cancer Care Cascade: evaluation of cervical cancer screening in HIV-positive women in Zimbabwe
Eliane Rohner, Katayoun Taghavi, Matthias Egger, Julia Bohlius - Clinical stage and treatment of epidemic Kaposi sarcoma in South Africa, Malawi, and Zambia: an international comparison
Eliane Rohner, Julia Bohlius - Cancer in HIV-infected persons in Malawi: a probabilistic record linkage study with the Malawi National Cancer Registry
Adrian Spörri, Julia Bohlius - Cancer in HIV-infected persons in Zimbabwe: a probabilistic record linkage study with the Zimbabwe National Cancer Registry
Adrian Spörri, Julia Bohlius - Risk of invasive cervical cancer in HIV-positive women on ART: a global analysis
Eliane Rohner, Lukas Bütikofer, Kurt Schmidlin, Marcel Zwahlen, Matthias Egger, Julia Bohlius - Risk of non-Hodgkin Lymphoma in HIV-positive adults on ART: a global analysis
Eliane Rohner, Lukas Bütikofer, Kurt Schmidlin, Marcel Zwahlen, Matthias Egger, Julia Bohlius - Access to clinical study reports from the European Medicines Agency and its effects on reporting bias
Thomy Tonia, Eliane Rohner, Julia Bohlius
Completed projects
Completed projects
- Cervical cancer risk in HIV-positive women in South Africa
- Risk of Kaposi Sarcoma in HIV-positive children and adults on ART: a global analysis
- Probabilistic record linkage studies to improve cancer ascertainment in pediatric and adult HIV cohorts in South Africa
- Association of human herpesvirus 8, HIV and sex: a systematic literature review and meta-analysis
- Kaposi Sarcoma incidence rates and risk factors in HIV-positive patients after starting combination antiretroviral therapy in Europe
- Kaposi sarcoma risk in HIV-positive population in Southern Africa
- Hodgkin lymphoma, CD4 and reverse causality
- HIV-1-related Hodgkin lymphoma in the era of combination antiretroviral therapy: incidence and evolution of CD4⁺ T-cell lymphocytes.
- Hodgkin lymphoma in the Swiss HIV Cohort Study.
Risk and prognosis of HIV-positive adults in Europe developing non-Hodgkin lymphoma - Incidence and risk factors of HIV-related non-Hodgkin’s lymphoma in the era of combination antiretroviral therapy: a European multicohort study.
- Prognosis of HIV-associated non-Hodgkin lymphoma in patients starting combination antiretroviral therapy.
- Prevention of infectious complications in cancer patients receiving myelosuppressive therapy
- Prophylaxis of infectious complications with colony-stimulating factors in adult cancer patients undergoing chemotherapy-evidence-based guidelines from the Infectious Diseases Working Party AGIHO of the German Society for Haematology and Medical Oncology (DGHO).
- 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours.
- Granulopoiesis-stimulating factors to prevent adverse effects in the treatment of malignant lymphoma.
- The effects of erythropoiesis-stimulating factors in cancer patients
- Effects of erythropoiesis-stimulating agents on fatigue- and anaemia-related symptoms in cancer patients: systematic review and meta-analyses of published and unpublished data.
- Cancer, meta-analysis and reporting biases: the case of erythropoiesis-stimulating agents.
- Epoetin and darbepoetin for managing anemia in patients undergoing cancer treatment: comparative effectiveness update [Internet].
- Erythropoietin or darbepoetin for patients with cancer.
- Twist and shout: one decade of meta-analyses of erythropoiesis-stimulating agents in cancer patients.
- Ten years of meta-analyses on erythropoiesis-stimulating agents in cancer patients.
- American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
- American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer.
- Erythropoietin or darbepoetin for patients with cancer--meta-analysis based on individual patient data.
- Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials.
- Erythropoiesis-stimulating agents in the treatment of cancer-associated anemia.
- Is intravenous iron supplementation with erythropoiesis-stimulating agents beneficial in cancer patients with anemia?